相关实验视频
Updated: Jun 18, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
接受化疗的患者的最佳高血糖值:瘤学家实践的横截面研究
Teresa M Salgado1, Poorva B Birari2, Mona Alshahawey2,3
1Department of Pharmacotherapy & Outcomes Science, School of Pharmacy and Massey Cancer Center, Virginia Commonwealth University, 410 N. 12Th Street PO Box 98053, Richmond, VA, 23298, USA. tmsalgado@vcu.edu.
瘤学家在接受化疗的癌症患者中使用不同的血糖标. 目前的指南缺乏具体建议,导致临床环境中的高血糖管理实践不一致.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 临床实践 临床实践
背景情况:
- 目前的瘤学指南缺乏针对癌症患者高血糖管理的具体建议.
- 高血糖症可能会使化疗治疗复杂化,并影响患者的治疗结果.
研究的目的:
- 确定瘤学家使用的禁食和随机血糖值和血红蛋白A1c (HbA1c) 标.
- 了解接受化疗的癌症患者高血糖管理的当前临床实践.
主要方法:
- 通过向瘤学家分发的问卷进行了一项全国性的横截面研究.
- 描述性统计分析了葡萄糖值和HbA1c目标.
- 主题分析探讨了瘤学家对高血糖管理的方法.
主要成果:
- 瘤学家报告了糖尿病患者和没有糖尿病患者的广泛的目标血糖水平.
- 禁食血糖和HbA1c是治疗意图治疗中化疗调整的主要指标.
- 随机血糖和患者报告的数据是缓和性意图化疗的关键.
结论:
- 对于接受化疗的癌症患者,瘤学家的目标血糖范围存在显著差异.
- 美国缺乏明确的指导方针,导致化学疗法期间高血糖症的临床管理不一致.
更多相关视频
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
相关概念视频
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...